Do gifts from the pharmaceutical industry affect trust in physicians?
- PMID: 23027114
Do gifts from the pharmaceutical industry affect trust in physicians?
Abstract
Background and objectives: Gifts to physicians from the pharmaceutical industry are receiving increased scrutiny, but no previous research has evaluated the effect of such gifts on trust. The goal of this study is to determine patient awareness of interactions between physicians and the pharmaceutical industry and to learn whether those interactions impact trust and the doctor-patient relationship.
Methods: A cross-sectional, self-administered 61-item survey was administered in five outpatient clinic waiting rooms at a US medical center in 2008. A total of 220 consecutive English-speaking adults were invited to participate. Main outcome measures included: (1) Awareness of physician relationship with the pharmaceutical industry, (2) Attitudes about physician acceptance of gifts, (3) Perceived impact of gifts on trust in physicians, and (4) Effect of gifts on intent to adhere to physician recommendations.
Results: A total of 192 individuals participated (87% response rate). While most were unaware of particular interactions between physicians and the pharmaceutical industry (12% to 60%, depending on activity), approximately half (51%) wanted to know if their physician accepted gifts >$100. A majority indicated they would have less trust in their physician if they learned he or she: accepted gifts >$100 (59%) or went on industry-sponsored trips (58%) or sporting events (54%). Further, 25% said they would be less likely to take a prescribed medication if their physician had recently accepted a gift in return for listening to a pharmaceutical representative's presentation about that drug.
Conclusions: Accepting gifts from the pharmaceutical industry has implications for the doctor-patient relationship. Doing so can undermine trust and affect patients' intent to adhere to medical recommendations.
Similar articles
-
Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia.Intern Med J. 2006 Sep;36(9):571-8. doi: 10.1111/j.1445-5994.2006.01151.x. Intern Med J. 2006. PMID: 16911549
-
A population-based study of the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers.Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1477-83. doi: 10.1016/j.ijrobp.2004.01.052. Int J Radiat Oncol Biol Phys. 2004. PMID: 15275735
-
Patients' awareness of and attitudes toward gifts from pharmaceutical companies to physicians.Int J Health Serv. 2009;39(2):405-14. doi: 10.2190/HS.39.2.j. Int J Health Serv. 2009. PMID: 19492632
-
Lets Do Lunch? The ethics of accepting gifts from the pharmaceutical industry.Can Nurse. 2008 Apr;104(4):30-5. Can Nurse. 2008. PMID: 18488765 Review.
-
Professionalism and physician interactions with industry.J Am Coll Radiol. 2006 May;3(5):325-32. doi: 10.1016/j.jacr.2006.01.022. J Am Coll Radiol. 2006. PMID: 17412075 Review.
Cited by
-
Health professional's exposure, attitude, and acceptance of drug promotion by industry representatives: A cross-sectional study in Ethiopia.Sci Prog. 2021 Apr-Jun;104(2):368504211029435. doi: 10.1177/00368504211029435. Sci Prog. 2021. PMID: 34191639 Free PMC article.
-
Knowledge, Beliefs and Attitudes of Patients and the General Public towards the Interactions of Physicians with the Pharmaceutical and the Device Industry: A Systematic Review.PLoS One. 2016 Aug 24;11(8):e0160540. doi: 10.1371/journal.pone.0160540. eCollection 2016. PLoS One. 2016. PMID: 27556929 Free PMC article.
-
Towards Patient-Centered Conflicts of Interest Policy.Int J Health Policy Manag. 2018 Feb 1;7(2):112-119. doi: 10.15171/ijhpm.2017.128. Int J Health Policy Manag. 2018. PMID: 29524935 Free PMC article.
-
Editorial: Is It Time to End Surgeon-Industry Consulting?Clin Orthop Relat Res. 2015 Sep;473(9):2727-30. doi: 10.1007/s11999-015-4434-3. Epub 2015 Jul 7. Clin Orthop Relat Res. 2015. PMID: 26150265 Free PMC article. No abstract available.
-
Awareness and Perceptions among Members of a Japanese Cancer Patient Advocacy Group Concerning the Financial Relationships between the Pharmaceutical Industry and Physicians.Int J Environ Res Public Health. 2022 Mar 15;19(6):3478. doi: 10.3390/ijerph19063478. Int J Environ Res Public Health. 2022. PMID: 35329160 Free PMC article.
MeSH terms
LinkOut - more resources
Medical